FRANCINI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 500
EU - Europa 232
AS - Asia 29
SA - Sud America 5
AF - Africa 4
Totale 770
Nazione #
US - Stati Uniti d'America 495
IT - Italia 108
IE - Irlanda 36
FR - Francia 23
VN - Vietnam 21
GB - Regno Unito 19
DE - Germania 11
SE - Svezia 10
CA - Canada 5
CL - Cile 5
MK - Macedonia 5
UA - Ucraina 5
CN - Cina 4
ZA - Sudafrica 4
FI - Finlandia 3
RU - Federazione Russa 3
IN - India 2
NL - Olanda 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
KR - Corea 1
Totale 770
Città #
Siena 67
Fairfield 61
Santa Cruz 42
Ashburn 41
Buffalo 38
Dublin 35
Houston 32
Seattle 31
Woodbridge 25
Dong Ket 21
Wilmington 20
Ann Arbor 18
Cambridge 13
Southend 13
Stockholm 10
Florence 7
Los Angeles 6
Ottawa 5
San Diego 4
Chicago 3
Cittaducale 3
Clearwater 3
Helsinki 3
Henderson 3
Las Vegas 3
Muizenberg 3
Munich 3
New York 3
Phoenix 3
Reggio Calabria 3
Riva 3
Struga 3
Auburn 2
Council Bluffs 2
Dallas 2
Guangzhou 2
Milan 2
Novi Sad 2
Prato 2
Provo 2
Rome 2
Saint Petersburg 2
San Francisco 2
Amsterdam 1
Athis-mons 1
Atlanta 1
Bloomfield 1
Bochum 1
Büdelsdorf 1
Carsoli 1
Cheyenne 1
Crotone 1
Dulles 1
Hillsboro 1
Kirkland 1
Kyiv 1
Lake Forest 1
Lincoln 1
Lviv 1
Martellago 1
Milpitas 1
Montreuil 1
Mumbai 1
Parlin 1
Pittsburgh 1
Poggibonsi 1
Reston 1
Santa Clara 1
Santiago 1
Scranton 1
Secaucus 1
Shanghai 1
Silverton 1
Strumica 1
Treviso 1
University Park 1
Zurich 1
Totale 584
Nome #
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer, file e0feeaa9-7ecb-44d2-e053-6605fe0a8db0 137
Survival following early-stage colon cancer: An ACCENT-based comparison of patients versus a matched international general population, file e0feeaa8-8e59-44d2-e053-6605fe0a8db0 115
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer, file e0feeaa4-c116-44d2-e053-6605fe0a8db0 109
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey, file e0feeaa5-ab4e-44d2-e053-6605fe0a8db0 108
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations, file e0feeaa8-4ca9-44d2-e053-6605fe0a8db0 98
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up, file e0feeaa8-4ca6-44d2-e053-6605fe0a8db0 96
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient, file e0feeaa9-2d67-44d2-e053-6605fe0a8db0 55
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy, file e0feeaaa-ef6c-44d2-e053-6605fe0a8db0 36
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab, file e0feeaa5-aab8-44d2-e053-6605fe0a8db0 5
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer, file e0feeaa8-7a9f-44d2-e053-6605fe0a8db0 3
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma, file e0feeaa4-dcd1-44d2-e053-6605fe0a8db0 2
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs., file e0feeaa4-df33-44d2-e053-6605fe0a8db0 2
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine, file e0feeaa4-e422-44d2-e053-6605fe0a8db0 2
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine., file e0feeaa4-e5bb-44d2-e053-6605fe0a8db0 2
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine, file e0feeaa4-e834-44d2-e053-6605fe0a8db0 2
Doxetacel and epirubicin compared with doxetacel and prednisone in advanced castrate-resistant prostate cancer: a randomized phase II study, file e0feeaa4-ef42-44d2-e053-6605fe0a8db0 2
null, file e0feeaa4-f5c8-44d2-e053-6605fe0a8db0 2
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials., file e0feeaa5-a0b9-44d2-e053-6605fe0a8db0 2
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803, file e0feeaa5-aa66-44d2-e053-6605fe0a8db0 2
High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effects, file e0feeaa7-17fa-44d2-e053-6605fe0a8db0 2
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse, file e0feeaa7-7417-44d2-e053-6605fe0a8db0 2
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro., file e0feeaa4-c052-44d2-e053-6605fe0a8db0 1
Folinic Acid and 5-Fluorouracil as adjuvant chemotherapy in colon cancer, file e0feeaa4-c0da-44d2-e053-6605fe0a8db0 1
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group., file e0feeaa4-c119-44d2-e053-6605fe0a8db0 1
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse, file e0feeaa4-db8d-44d2-e053-6605fe0a8db0 1
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin, file e0feeaa4-dfbf-44d2-e053-6605fe0a8db0 1
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial)., file e0feeaa4-e05d-44d2-e053-6605fe0a8db0 1
Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients., file e0feeaa4-e307-44d2-e053-6605fe0a8db0 1
Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer., file e0feeaa4-e762-44d2-e053-6605fe0a8db0 1
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients., file e0feeaa4-e7de-44d2-e053-6605fe0a8db0 1
Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer., file e0feeaa4-ea20-44d2-e053-6605fe0a8db0 1
Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate, file e0feeaa4-f036-44d2-e053-6605fe0a8db0 1
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma, file e0feeaa4-f11f-44d2-e053-6605fe0a8db0 1
Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases, file e0feeaa4-f211-44d2-e053-6605fe0a8db0 1
A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity, file e0feeaa5-a3df-44d2-e053-6605fe0a8db0 1
Treatment of bone metastases with dichloromethylene biphosphonate, file e0feeaa5-e908-44d2-e053-6605fe0a8db0 1
Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mytomicin C, file e0feeaa5-e92a-44d2-e053-6605fe0a8db0 1
Hypercalcemia in breast cancer, file e0feeaa5-f0c7-44d2-e053-6605fe0a8db0 1
Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation, file e0feeaa7-5e68-44d2-e053-6605fe0a8db0 1
Bioactivity of GM-CSF and IL-2 in cancer patients, file e0feeaa8-1064-44d2-e053-6605fe0a8db0 1
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme, file e0feeaa8-50df-44d2-e053-6605fe0a8db0 1
Determinants of early mortality among 37,568 patients with colon cancer who participated in 25 clinical trials from the adjuvant colon cancer endpoints database, file e0feeaa8-8e57-44d2-e053-6605fe0a8db0 1
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer, file e0feeaa8-91c2-44d2-e053-6605fe0a8db0 1
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer, file e0feeaa8-afce-44d2-e053-6605fe0a8db0 1
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer, file e0feeaaa-55ed-44d2-e053-6605fe0a8db0 1
Recruitment of dendritic cells and enhanced antigen specific immune reactivity in cancer patients treated with hrGM-CSF (molgramostim) and hrIL-2: results from a Phase Ib clinical trial, file e0feeaaa-6d46-44d2-e053-6605fe0a8db0 1
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials, file e0feeaab-06dd-44d2-e053-6605fe0a8db0 1
Totale 810
Categoria #
all - tutte 5.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.489


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 3 5 8
2019/2020129 3 3 6 5 9 8 10 27 21 15 11 11
2020/2021198 7 12 9 10 15 22 18 20 12 27 13 33
2021/2022204 12 14 8 20 20 9 11 12 11 9 60 18
2022/2023141 7 6 50 33 10 22 5 0 0 2 5 1
2023/202488 4 3 8 19 8 14 23 0 1 8 0 0
Totale 810